Athenex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Athenex and buy or sell other stocks, ETFs, and their options commission-free!

About ATNX

Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. 

CEO
Yiu Nam Lau, MD
CEOYiu Nam Lau, MD
Employees
Employees
Headquarters
Buffalo, New York
HeadquartersBuffalo, New York
Founded
2003
Founded2003
Employees
Employees

ATNX Key Statistics

Market cap
131.70K
Market cap131.70K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.93K
Average volume1.93K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.00
52 Week high$6.00
52 Week low
$0.0003
52 Week low$0.0003

People also own

Based on the portfolios of people who own ATNX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.